Franklin Resources
NGNE icon

Franklin Resources’s Neurogene NGNE Stock Holding History

Franklin Resources’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.42M Buy
+204,280
New +$5.62M ﹤0.01% 1481
2024
Q4 		– Sell
-7,050
Closed -$351K – 2988
2024
Q3 		$351K Buy
+7,050
New +$273K ﹤0.01% 2437
2018
Q2 		– Sell
-67,212
Closed -$18.9M – 1511
2018
Q1 		$18.9M Buy
67,212
+482
+0.7% +$133K 0.01% 798
2017
Q4 		$15.7M Buy
66,730
+718
+1% +$168K 0.01% 850
2017
Q3 		$18.7M Hold
66,012
– – 0.01% 811
2017
Q2 		$18.6M Hold
66,012
– – 0.01% 810
2017
Q1 		$22M Sell
66,012
-3,600
-5% -$1.26M 0.01% 761
2016
Q4 		$23M Sell
69,612
-1,975
-3% -$531K 0.01% 757
2016
Q3 		$19.1M Buy
71,587
+9,290
+15% +$1.87M 0.01% 821
2016
Q2 		$8.25M Hold
62,297
– – ﹤0.01% 1005
2016
Q1 		$11M Buy
62,297
+4,380
+8% +$851K 0.01% 961
2015
Q4 		$14.5M Buy
57,917
+2,565
+5% +$675K 0.01% 922
2015
Q3 		$15.6M Buy
55,352
+25,000
+82% +$5.76M 0.01% 913
2015
Q2 		$4.21M Buy
30,352
+905
+3% +$138K ﹤0.01% 1202
2015
Q1 		$5.05M Hold
29,447
– – ﹤0.01% 1175
2014
Q4 		$4.42M Sell
29,447
-1,128
-4% -$161K ﹤0.01% 1206
2014
Q3 		$4.07M Sell
30,575
-5,107
-14% -$779K ﹤0.01% 1215
2014
Q2 		$6.69M Buy
35,682
+5,515
+18% +$1.06M ﹤0.01% 1133
2014
Q1 		$7.68M Buy
+30,167
New +$7.75M ﹤0.01% 1084

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Franklin Resources's NGNE Position: Q2 2026 in Review

Franklin Resources opened a new position in Neurogene (NGNE) in Q2 2026: 204,280 shares worth $6.42M. The stake represents ﹤0.01% of the portfolio and ranks #1481 among its holdings. This is a return to the name: Franklin Resources previously reported a position in NGNE as recently as Q3 2024.

Franklin Resources first reported a position in NGNE in Q1 2014 and has held it in 19 quarters since. The position peaked at $23M in Q4 2016. 112 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • Franklin Resources held 204,280 shares of Neurogene worth $6.42M as of Q2 2026.
  • Neurogene was a new Franklin Resources position in Q2 2026.
  • Neurogene made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1481 holding.
  • Franklin Resources first reported a position in Neurogene in Q1 2014 and has held it in 19 quarters since.
  • Franklin Resources's Neurogene position peaked at $23M in Q4 2016.
  • 112 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.